Billing Transparency: Your #1 Provider Filter
Jillian Foglesong Stabile, MD
Board-certified Family Medicine · Diplomate, ABOM · Reviewed Jun 4, 2026
You compared the medication. You read the reviews. You checked the dose schedule. Then a charge you never agreed to hit your card three weeks later, and the support line went quiet. This is the part almost nobody screens for, and it is the part that decides whether your next year on a GLP-1 feels calm or chaotic. The filter that protects you is not the drug. It is the billing.
The short answer
A transparent GLP-1 provider shows you four numbers before any charge: the full monthly cost, what happens when your dose changes, any lab or add-on fees, and how to cancel at any time. If you cannot find all four before entering a card number, that is your answer.
What you will learn
- The four billing numbers a good GLP-1 provider must show you up front
- Why hidden charges, not the medication, drive most cancellations
- How to test a provider's billing honesty in five minutes
- What current GLP-1 prices actually look like in 2026, with sources
- The single quiet question that exposes a weak refund policy
Chapter 01 · The filter
Billing transparency protects you more than any drug comparison
A clear billing policy is the strongest predictor of a calm year on a GLP-1. The medication you start with may change. Your dose will likely change. The provider's honesty about money is the one thing that should stay constant. Screen for that first, and most other risks shrink.
Billing transparency means no guessing. A transparent provider tells you the recurring monthly charge, what happens to that charge if your physician adjusts your plan, whether labs cost extra, and exactly how to stop. You should be able to read all of this before you enter a card number. If you have to email support to learn the price, that is your first red flag.
Here is the simple test. Open the provider's pricing page. Can you find the monthly cost in under thirty seconds? Can you find the cancellation steps in under a minute? If either answer is no, the friction is on purpose.
Because the science is increasingly shared, and the billing is not. Many providers can connect you with a licensed physician for semaglutide or tirzepatide. Far fewer will tell you, in writing, what you will pay across a full year. Cost is one of the most common reasons people stop GLP-1 treatment, not side effects. About half of GLP-1 users say the drugs are difficult to afford, and roughly one in seven who quit point to cost as the reason.1
The question is not only whether a provider can get you the medication. It is whether they will be honest with you about money for the next twelve months.
Chapter 02 · The checklist
The four numbers that separate honest providers from the rest
A good GLP-1 provider shows you four numbers before charging anything: the full monthly cost, the cost as your dose changes, any lab or add-on fees, and the cancellation path. Most surprise charges trace back to a provider that disclosed one of these four and quietly hid the other three.
| Number to ask for | What honest looks like | Red flag |
|---|---|---|
| Full monthly cost | One clear figure, not "starting at" or "as low as" | Teaser price in month one that jumps later |
| Cost when dose changes | Range stated in writing; flat or tiered pricing both fine if disclosed | Vague "it depends" with no range |
| Labs and add-on fees | Named before checkout; bundled or itemized, but stated | Lab fees appear as surprise line items after the first bill |
| Cancellation path | Cancel in your account, a few clicks, no phone call required | Cancel only by phone during business hours; retention scripts |
All four numbers should be visible before you enter a card number. Swipe to see the full table on a phone.
The cancellation path is the number that exposes everyone. A trustworthy provider lets you cancel in your account, in a few clicks, with no phone call and no retention script. If canceling requires a call during business hours, or a chat agent who keeps checking with a manager, the friction is the policy. You should be able to leave as easily as you joined.
GLP-1 plans are physician-managed, and your physician may adjust your plan over time. A transparent provider tells you up front whether that adjustment changes your bill. Some keep one flat price across plan changes. Others charge more at different points. Neither is wrong. Hiding which one they do is.
The simple rule
Never accept a vague response on pricing. If a provider cannot tell you the full cost, the recurring charge, and how to cancel at any time before you sign up, keep looking.
What would you actually pay?
30-second cost calculator
Chapter 03 · The screen
How to test a provider's billing honesty in five minutes
You can screen any GLP-1 provider for billing honesty in about five minutes, before you ever sign up. Open three pages, ask one question, and watch how they respond. Honest providers make this easy. The rest get evasive fast, and that evasiveness is the answer.
Start on the pricing page. Read it like a skeptic.
- Find the recurring monthly price. Time yourself. Under thirty seconds is a good sign.
- Find the cancellation steps. If the word “cancel” only appears in the fine print, note that.
- Search the page for “labs,” “consult,” and “shipping.” See if extra fees are named or buried.
- Message support with one question: “What will I pay in total over my first year, including labs?” A confident, specific answer is a green signal. A deflection is a red one.
- Read the refund policy out loud. If you cannot understand it, it was not written for you to understand.
This screen costs you nothing and saves you months. Ask the one-year question: a confident answer in writing is the standard you deserve.
Chapter 04 · The prices
What GLP-1 prices actually look like in 2026
GLP-1 pricing shifted in 2026, which makes transparency more important, not less. New federal pricing programs lowered some cash prices, but the headline number is rarely the number you pay. The right filter is still the same: a provider who shows you the full, recurring cost beats one who advertises the lowest sticker.
Under the federal most-favored-nation program on TrumpRx, injectable Wegovy® fell to an average around $350 and as low as $199 depending on dose strength. The Wegovy® pill dropped to as low as $149, and Zepbound® landed near $346 on average and as low as $299.2 Separately, a Medicare GLP-1 Bridge starts July 1, 2026 and runs through December 31, 2027, offering eligible Part D beneficiaries a flat $50 monthly copay on certain GLP-1 drugs.3
$149
as low as, for the Wegovy pill under TrumpRx most-favored-nation pricing, 2026
~50%
of GLP-1 users report the drugs are difficult to afford (KFF, 2025)
Prices reflect 2026 federal program figures and are subject to eligibility rules. Individual costs vary by dose, coverage, and provider.
These numbers are real, but they come with eligibility rules and dose tiers. That is exactly why a single advertised price tells you little. The medication can cost very different amounts depending on your dose, your coverage, and your provider's fee structure. A low headline price can hide consult fees, lab fees, and a recurring charge that climbs. The meaningful comparison is never sticker against sticker. It is total honest cost against total honest cost. US rules on recurring charges expect the full cost and the cancellation terms to be clear before you pay.5
Chapter 05 · Compounded
The myth that compounded must mean confusing pricing
Compounded GLP-1 medication does not have to mean murky billing. A compounded medication is a distinct preparation made by a state-licensed 503A pharmacy under a patient-specific prescription. It is not FDA-approved and is not equivalent to a branded product. A serious provider can price it as clearly as anything else. The confusion is a choice some providers make, not a rule.
The compounding landscape did shift in 2026. In April 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list, citing no clinical need now that shortages have resolved, with public comment open through June 29, 2026. That proposal addresses 503B outsourcing facilities. It does not change 503A patient-specific compounding, which is the lane a transparent provider should be able to explain to you in one sentence.4
So if a provider gets vague about what you are getting and what it costs, that is not the regulation talking. That is the provider. A good provider tells you plainly whether you are receiving a branded product or a patient-specific compounded preparation, and exactly what both will cost over time.
This article is educational and is not medical advice. It does not diagnose, recommend, or prescribe. Treatment decisions are made by a licensed clinician. Individual results vary.
A provider that meets the full billing standard earns your year. The standard in practice, in line with the FTC’s negative-option expectations: full cost disclosed before checkout, no charge until your physician approves, and cancel at any time in your account with no phone call required. sipra publishes its billing rules openly, and you can compare it against the checklist above.
Three steps before you pay anyone
You do not need to be a billing expert. You need a habit. Run these three steps before you sign up with any GLP-1 provider.
- Find the four numbers. Full monthly cost, cost when your dose changes, lab fees, and the cancellation path. All four, in writing, before checkout.
- Run the five-minute screen. Time the price search, time the cancel search, ask the one-year question, and read the refund policy out loud.
- Demand a clean exit. If you cannot cancel in your account without a phone call, that tells you how the provider sees you. Keep looking.
The right provider makes this easy.
Lose weight with a plan made just for you
- Same-day doctor visits and prescriptions
- Semaglutide, tirzepatide & other GLP-1s
- FSA & HSA eligible with all plans
From$79/mo
+ Sipra membership*
*Price includes medication only. Active $99/mo Sipra membership required.
Frequently asked questions
Sources
- KFF (Kaiser Family Foundation). "KFF Health Tracking Poll: the public’s views on GLP-1 drugs and affordability." 2025. kff.org
- AJMC. "Trump Announces Deals With Eli Lilly, Novo Nordisk for Lower Weight Loss Drug Prices." Updated 2026. ajmc.com
- CMS (Centers for Medicare & Medicaid Services). "Medicare GLP-1 coverage and the GLP-1 Bridge." Accessed June 2026. cms.gov
- U.S. Food and Drug Administration. "FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List." April 30, 2026. fda.gov
- U.S. Federal Trade Commission. "Negative Option Rule." Accessed June 2026. ftc.gov
Trademark attribution. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Zepbound® is a trademark of Eli Lilly and Company. sipra is not affiliated with or endorsed by these companies.
Medically reviewed by
Jillian Foglesong Stabile, MD, FAAFP, DABOM
Was this helpful?
Keep reading
Weight LossHow GLP-1 Treatment With sipra Works, Step by Step
16 min read
Weight LossGLP-1 weight loss 101: how semaglutide and tirzepatide actually work
17 min read
Weight LossThe Real Cost of GLP-1 Medication: Every Number Before Your Card Is Charged
16 min read
Weight LossBranded vs compounded GLP-1s: the real difference in 2026
9 min read
Weight LossGLP-1 Myths That Won't Die (and the Facts That Beat Them)
9 min read
Weight LossGLP-1 Side Effects and How to Manage Them, Week by Week
10 min read
Weight LossHow GLP-1s work in the body: the science of appetite and satiety
9 min read
Weight LossWhat 503A compounding means (and why your prescription is made for you)
11 min read